SCHEMBL64209

SCHEMBL64209

CC1(C)CNCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3832428 0.97 ALPL (0.40)
Ammonia Solution, Strong SCHEMBL21436559 0.97
Hydrochloric Acid SCHEMBL14335493 0.97
Methylamine SCHEMBL27813413 0.94 ALPL (0.39)
Oxalic Acid SCHEMBL21436329 0.84 ALPL (0.33)
Acetic Acid SCHEMBL1871815 0.84 ALPL (0.33)
SCHEMBL6551757 0.81
SCHEMBL2918450 0.81
Succinic Acid SCHEMBL21436621 0.79 EGLN1 (0.38)
Fumaric Acid SCHEMBL21436601 0.79 TSHR (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1041 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026097624-A1 METHOD FOR PREPARING CHLORINE-RESISTANT NANOFILTRATION MEMBRANE, AND CHLORINE-RESISTANT NANOFILTRATION MEMBRANE PREPARED THEREWITH 沃顿科技股份有限公司 2026-05-15 WO claimed
US-20250051347-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER Hinova Pharmaceuticals, Inc. (CN) 2025-02-13 US claimed
CN-118356816-A Acid-resistant composite nanofiltration membrane based on polytetrafluoroethylene base membrane improvement and preparation method and application thereof 浙江理工大学 2024-07-19 CN claimed
EP-4378936-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER Hinova Pharmaceuticals Inc. (CN) 2024-06-05 EP claimed
CN-117815933-A High-flux composite membrane based on polybasic amino acid modification and preparation method thereof 厦门百霖净水科技有限公司 2024-04-05 CN claimed
EP-3660069-B1 FAST CURING EPOXY SYSTEMS EVONIK OPERATIONS GMBH (DE) 2024-01-03 EP claimed
CN-113559728-B Acid-resistant composite nanofiltration membrane and preparation method thereof 中国乐凯集团有限公司 2023-11-24 CN claimed
CN-108676171-B Olefin copper coordination polymer with orange fluorescence effect and preparation method thereof 镇江市高等专科学校 2023-08-15 CN claimed
WO-2023068516-A1 LOW-WATER TYPE CARBON DIOXIDE ABSORBENT AND METHOD FOR CAPTURING CARBON DIOXIDE BY USING SAME 주식회사 씨이텍 2023-04-27 WO claimed
CN-115677667-A Bifunctional chimera heterocyclic compound and application thereof as androgen receptor degrading agent 海创药业股份有限公司 2023-02-03 CN claimed
US-20040024210-A1 New compounds PROXIMAGEN NEUROSCIENCE PLC (GB) 2004-02-05 US claimed
WO-2004000828-A1 NEW COMPOUNDS USEFUL FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS BIOVITRUM AB (SE) 2003-12-31 WO claimed
EP-0988292-B1 PIPERAZINE DERIVATIVES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS SCHERING AG (DE) 2003-02-12 EP claimed
EP-1228069-A2 BICYCLIC AND TRICYCLIC HETEROAROMATIC COMPOUNDS NEUROGEN CORPORATION (US) 2002-08-07 EP claimed
EP-1131306-A2 ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2001-09-12 EP claimed
WO-2001034603-A2 BICYCLIC AND TRICYCLIC HETEROAROMATIC COMPOUNDS NEUROGEN CORPORATION (US) 2001-05-17 WO claimed
WO-2000029406-A2 NOVEL ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 2000-05-25 WO claimed
WO-2000003595-A1 COMPOSITIONS AND METHODS FOR PROTECTING CULTIVATED PLANTS FROM HERBICIDAL INJURY MICHIGAN STATE UNIVERSITY (US) 2000-01-27 WO claimed
EP-0626965-A1 PROCESS FOR SEPARATING STEREOISOMERS OF FOLINIC ACID BRACCO S.p.A. (IT) 1994-12-07 EP claimed
WO-1993017022-A1 PROCESS FOR SEPARATING STEREOISOMERS OF FOLINIC ACID BRACCO S.P.A. (IT) 1993-09-02 WO claimed